Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lithium Americas Corp (LAC) vs Revvity Inc (RVTY) Price & Performance

Lithium Americas CorpTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Lithium Americas Corp vs Revvity Inc — how do they compare? Lithium Americas Corp trades at $2.93 (market cap $1.01B), while Revvity Inc trades at $106.58 (market cap $11.87B). The key difference: Revvity Inc is far larger — about 11.8× Lithium Americas Corp's market cap, and Revvity Inc pays a 0.26% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals.

LACRVTY
Market Cap
$1.01B$11.87B
Sector
Basic MaterialsTechnology
52-Week High
$10.05$117.75
52-Week Low
$2.55$82.26
Enterprise Value
$1.13B$14.36B
Dividend Yield
0.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lithium Americas Corp

Lithium Americas (LAC) trades at $2.90, down 1.69% amid bearish technical signals despite recent earnings beats. The company shows negative profitability with ROE at -11.35% and net income of -$122.09M for 2025, though it maintains strong financing cash flow of $1.14B. Construction milestones at Thacker Pass project progress, with 2026 expected to be pivotal for operational developments according to company guidance.

Investment outlook balances significant project potential against substantial execution risks. While analyst consensus leans positive with 47% buy ratings and no sell recommendations, the stock faces headwinds from negative cash flow from operations and high capital expenditure requirements. Key risks include dilution from share issuances and sensitivity to lithium market dynamics.

Revvity Inc

RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.

The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.

Returns comparison

Trailing returns across standard periods

About Lithium Americas Corp

Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.

Read more on LAC

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY